| # | Drug | Count |
|---|---|---|
| 0 | ADALIMUMAB | 6 |
| 1 | ADALIMUMAB-AATY | 6 |
| 2 | ADALIMUMAB-ADAZ | 6 |
| 3 | ADALIMUMAB-FKJP | 6 |
| 4 | DENOSUMAB | 6 |
| 5 | APREMILAST | 5 |
| 6 | BARICITINIB | 5 |
| 7 | ETANERCEPT | 5 |
| 8 | GOLIMUMAB | 5 |
| 9 | INFLIXIMAB | 5 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | BARICITINIB | 5 | 0.0016 |
| 1 | GOLIMUMAB | 5 | 0.0004 |
| 2 | TOFACITINIB CITRATE | 5 | 0.0004 |
| 3 | ADALIMUMAB-FKJP | 6 | 0.0001 |
| 4 | ADALIMUMAB-AATY | 6 | 0.0001 |
| 5 | ADALIMUMAB-ADAZ | 6 | 0.0001 |
| 6 | UPADACITINIB | 5 | 0.0001 |
| 7 | VEDOLIZUMAB | 5 | 0.0001 |
| 8 | USTEKINUMAB | 5 | 0.0000 |
| 9 | LURASIDONE HYDROCHLORIDE | 1 | 0.0000 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-17A Antagonist [EPC] | 5 | 0.0001 |
| 1 | Integrin Receptor Antagonist [EPC] | 5 | 0.0001 |
| 2 | Interleukin-12 Antagonist [EPC] | 5 | 0.0000 |
| 3 | Interleukin-23 Antagonist [EPC] | 5 | 0.0000 |
| 4 | Interleukin-6 Receptor Antagonist [EPC] | 5 | 0.0000 |
| 5 | Janus Kinase Inhibitor [EPC] | 5 | 0.0000 |
| 6 | Phosphodiesterase 4 Inhibitor [EPC] | 5 | 0.0000 |
| 7 | RANK Ligand Inhibitor [EPC] | 6 | 0.0000 |
| 8 | CD20-directed Cytolytic Antibody [EPC] | 5 | 0.0000 |
| 9 | Folate Analog Metabolic Inhibitor [EPC] | 4 | 0.0000 |